FDA Inspection 819585 — Corden Pharma Brussels SA
The FDA completed an inspection of Corden Pharma Brussels SA on January 30, 2013 in Brussels. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brussels (Belgium)